Records containing: Refractory Myasthenia Gravis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-18A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of HN2302 in Patients With Refractory Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2026-02-12Dose-escalation Study to Assess the Safety, Tolerability, and Preliminary Efficacy of HN2301 in Patients With Refractory Myasthenia Gravis (MG)
-
CLINICAL_TRIALS study record update · 2025-11-21Exploratory Clinical Trial of Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2022-05-02Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis
-
CLINICAL_TRIALS study record update · 2013-01-16Phase 1-2 Pilot Study of Rituximab (Rituxan) in Refractory Myasthenia Gravis.
- Organize your saved records without ads with Plus.